Moreover, members of the mTOR signaling pathway and eukaryotic translation initiation factors (eIFs) have recently been identified as potential biomarkers for HCC, and their expression patterns depend on different HCC aetiologias, such as HBV, HCV and non-virus-related HCC [78]. Here, MTOR is linked to hepatocellular carcinoma.